Cetera Advisor Networks’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$9.47M Buy
22,650
+9,463
+72% +$3.96M 0.05% 392
2023
Q4
$5.37M Buy
13,187
+674
+5% +$274K 0.03% 545
2023
Q3
$4.35M Buy
12,513
+1,968
+19% +$684K 0.03% 569
2023
Q2
$3.71M Sell
10,545
-3,164
-23% -$1.11M 0.03% 620
2023
Q1
$4.32M Buy
13,709
+2,190
+19% +$690K 0.03% 542
2022
Q4
$3.33M Buy
11,519
+4,488
+64% +$1.3M 0.03% 602
2022
Q3
$2.04M Buy
7,031
+374
+6% +$108K 0.03% 584
2022
Q2
$1.88M Buy
6,657
+170
+3% +$47.9K 0.02% 613
2022
Q1
$1.69M Buy
6,487
+1,904
+42% +$497K 0.02% 677
2021
Q4
$1.01M Buy
4,583
+381
+9% +$83.6K 0.01% 901
2021
Q3
$762K Buy
4,202
+152
+4% +$27.6K 0.01% 970
2021
Q2
$817K Buy
4,050
+613
+18% +$124K 0.01% 917
2021
Q1
$739K Sell
3,437
-51
-1% -$11K 0.02% 705
2020
Q4
$824K Sell
3,488
-29
-0.8% -$6.85K 0.02% 603
2020
Q3
$957K Sell
3,517
-474
-12% -$129K 0.02% 492
2020
Q2
$1.16M Buy
3,991
+345
+9% +$100K 0.03% 423
2020
Q1
$868K Buy
3,646
+1
+0% +$238 0.03% 444
2019
Q4
$800K Buy
3,645
+634
+21% +$139K 0.02% 568
2019
Q3
$513K Buy
3,011
+321
+12% +$54.7K 0.02% 694
2019
Q2
$490K Buy
2,690
+428
+19% +$78K 0.02% 688
2019
Q1
$413K Buy
2,262
+748
+49% +$137K 0.01% 733
2018
Q4
$251K Sell
1,514
-1,532
-50% -$254K 0.01% 839
2018
Q3
$589K Buy
+3,046
New +$589K 0.02% 582
2018
Q2
Sell
-1,830
Closed -$299K 967
2018
Q1
$299K Buy
1,830
+64
+4% +$10.5K 0.01% 667
2017
Q4
$263K Buy
1,766
+300
+20% +$44.7K 0.01% 796
2017
Q3
$222K Sell
1,466
-115
-7% -$17.4K 0.01% 806
2017
Q2
$207K Buy
+1,581
New +$207K 0.01% 839
2016
Q4
Sell
-2,545
Closed -$222K 1014
2016
Q3
$222K Buy
+2,545
New +$222K 0.01% 895